To investigate the effectiveness of dynamic susceptibility contrast-perfusion weighted imaging (DSCPWI) in predicting the progression-free survival (PFS) and chemotherapeutic responsiveness of primary central nervous system lymphoma (PCNSL) before high-dose methotrexate-based chemotherapy. DSCPWI was used to analyze 35 patients who had pathology-confirmed PCNSL. Relative cerebral blood volume (rCBV), relative cerebral blood flow (rCBF), relative mean transit time (rMTT) and relative time to peak (rTTP) were measured on parameter maps. The 5th, 50th and 95th percentile values of every parameter were recorded for enhanced tumors and compared with the parameters of the normally contralateral hemisphere. The ratio of each PWI parameter (rrCBV, rrCBF, rrMTT, rrTTP) was obtained. The influence of parameters on responsiveness and PFS was investigated by univariate Kaplan-Meier analysis and logistic regression and Cox regression for multivariate analysis with a stepwise method. Differences in PWI parameters between the higher and lower vascular endothelial growth factor (VEGF) groups were assessed by the Mann-Whitney U test. Eighteen patients achieved a complete response (CRi) after four initial cycles of chemotherapy. Patients with lower age (p = 0.011), higher VEGF (p < 0.001), higher Karnofsky Performance Status (KPS) (p < 0.001), higher rrCBV(95%) (p < 0.001), higher rrCBV(50%) (p = 0.016), higher rrCBF(95%) (p < 0.001), higher rrCBF(50%) (p = 0.002) showed better PFS; there was difference on age(p = 0.044), KPS (p < 0.001), VEGF (p < 0.001), rrCBV(95%) (p = 0.018), rrCBF(95%) (p = 0.018), rrCBF(50%) (p = 0.007) between CRi and nonCR(i). Multivariate analysis demonstrated that rrCBF(95%) (p = 0.037, 95% confidence interval: 1.065-7.206) was significantly associated with PFS. rCBV and rCBF may be used to assess the responsiveness and prognosis of PCNSL, and rCBF(95%) may be a better predictor. (C) 2021 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
It is difficult to differentiate between primary central nervous system lymphoma and primary glioblastoma due to their similar MRI findings. This study aimed to assess whether pharmacokinetic parameters derived from dynamic contrast-enhanced MRI could provide valuable insights for differentiation. Seventeen cases of primary central nervous system lymphoma and twenty-one cases of glioblastoma as confirmed by pathology, were retrospectively analyzed. Pharmacokinetic parameters, including Ktrans, Kep, Ve, and the initial area under the Gd concentration curve, were measured from the enhancing tumor parenchyma, peritumoral parenchyma, and contralateral normal parenchyma. Statistical comparisons were made using Mann-Whitney U tests for Ve and Matrix Metallopeptidase-2, while independent samples t-tests were used to compare pharmacokinetic parameters in the mentioned regions and pathological indicators of enhancing tumor parenchyma, such as vascular endothelial growth factor and microvessel density. The pharmacokinetic parameters with statistical differences were evaluated using receiver-operating characteristics analysis. Except for the Wilcoxon rank sum test for Ve, the pharmacokinetic parameters were compared within the enhancing tumor parenchyma, peritumoral parenchyma, and contralateral normal parenchyma of the primary central nervous system lymphomas and glioblastomas using variance analysis and the least-significant difference method. Statistical differences were observed in Ktrans and Kep within the enhancing tumor parenchyma and in Kep within the peritumoral parenchyma between these two tumor types. Differences were also found in Matrix Metallopeptidase-2, vascular endothelial growth factor, and microvessel density within the enhancing tumor parenchyma of these tumors. When compared with the contralateral normal parenchyma, pharmacokinetic parameters within the peritumoral parenchyma and enhancing tumor parenchyma exhibited variations in glioblastoma and primary central nervous system lymphoma, respectively. Moreover, the receiver-operating characteristics analysis showed that the diagnostic efficiency of Kep in the peritumoral parenchyma was notably higher. Pharmacokinetic parameters derived from dynamic contrast-enhanced MRI can differentiate primary central nervous system lymphoma and glioblastoma, especially Kep in the peritumoral parenchyma.
9 April 2025 in Chinese Journal of Academic Radiology
Background Screening for obstructive coronary artery disease (CAD) is crucial. Conventional cardiovascular risk models have relatively poor performance in predicting obstructive coronary artery disease. CAC score (CACS) is the strongest predictor of obstructive CAD. This study developed and validated the performance of obstructive CAD prediction model (PREDICT-OCAD) and further studied that PREDICT-OCAD can save unnecessary expense by correctly reclassifying patients as low likelihood for obstructive CAD without further testing. Objective To develop and validate the performance of coronary artery calcium score (CACS) based nomogram for predicting obstructive coronary artery disease (CAD). Methods 4994 participants undergoing CACS and coronary CT angiography (CCTA) from four medical centers were retrospectively included for model development (n = 2649), internal (n = 1135) and external validation (n = 1210). Coronary artery stenosis on CCTA and CACS were measured. Regression models were developed and compared. A nomogram was generated to identify potential predictors associated with obstructive CAD. Results In development sets, CACS had incremental value for prediction of obstructive CAD compared to cardiovascular risk factors-based model, with higher area under the curves (AUCs) (0.848 [95%CI: 0.830–0.866] vs. 0.879 [95%CI: 0.857-0.900]; P = 0.029), net reclassification improvement (NRI) index (0.577 [95%CI: 0.482–0.672]; P < 0.001) and integrated discrimination improvement (IDI) index (0.186 [95%CI: 0.159–0.213]; P < 0.001). A nomogram (PREDICT-OCAD) provided significantly incremental discriminate value to CACS (AUC: 0.893 [95%CI: 0.869–0.917]; P = 0.027), which was confirmed by continuous NRI (0.392 [95%CI: 0.247–0.538]; P < 0.001), categorical NRI (0.069 [95%CI: 0.001–0.137]; P = 0.045) and IDI (0.039 [95%CI: 0.02–0.0580]; P < 0.001), resulted in the revision of management plan as determined by cardiovascular risk factors in 18.6% (492/2649) of patients, of whom 77.2% (380/492) were correctly reclassified. Conclusion Our developed simple-to-use CACS based nomogram model (PREDICT-OCAD) performs better than conventional clinical model or CACS alone, which is a useful tool for risk stratification of CAD in primary health system.
6 February 2026 in Journal of Imaging Informatics in Medicine
Background: Chronic coronary syndrome (CCS) requires accurate risk stratification for optimized management. Pericoronary adipose tissue (PCAT) inflammation is closely associated with plaque progression, and coronary computed tomography angiography (CCTA)-based radiomics may provide information beyond the traditional fat attenuation index (FAI). Objective: To assess the value of PCAT radiomics and its combination with one-stop CCTA parameters for identifying CCS patients who are classified as high-risk by the 2024 European Society of Cardiology (ESC) guideline-recommended risk factor-clinical (RF-CL) model. Methods: We retrospectively enrolled 175 CCS patients who underwent CCTA between January 2024 and January 2026. According to the 2024 ESC guideline-recommended RF-CL model, patients were classified as high risk (>15%, n = 77) or low risk (≤15%, n = 98). PCAT radiomics features were extracted from the three major coronary arteries, and FAI, computed tomography-derived fractional flow reserve (CT-FFR), coronary artery calcium score (CACS), and the Coronary Artery Disease Reporting and Data System (CAD-RADS) were analyzed. Results: Significant between-group differences were found in right coronary artery (RCA) FAI, left anterior descending (LAD) FAI, CACS, CAD-RADS, distal CT-FFR at the most stenotic plaque, and distal vessel CT-FFR, but not left circumflex (LCX) FAI. Distal vessel CT-FFR showed better discrimination than lesion-specific CT-FFR (area under the receiver operating characteristic curve [AUC] 0.782 vs. 0.698). The RCA PCAT radiomics model outperformed RCA FAI in the testing set (AUC 0.729 vs. 0.620). The integrated model achieved the best performance, with AUCs of 0.860 and 0.823 in the training and testing sets. Conclusion: PCAT radiomics, especially when integrated with one-stop CCTA parameters, improves the identification of CCS patients classified as high-risk by the RF-CL model. Prospective studies with hard cardiovascular outcomes are required to validate its prognostic value and to determine whether this imaging-based strategy can guide therapeutic decision-making.